This bill, the "End Needless Distribution of 7-OH Act" (END 7-OH Act), was introduced in the House on March 19, 2026. It would change the Controlled Substances Act by adding 7-hydroxymitragynine, including its synthetic equivalents, to Schedule I. The bill text says this change does not apply to 7-hydroxymitragynine that is naturally contained in the kratom plant (Mitragyna speciosa). The bill was referred to the Committee on Energy and Commerce and the Committee on the Judiciary.
If this bill becomes law, synthetic 7-hydroxymitragynine would be listed as a Schedule I substance under the Controlled Substances Act. The bill text does not describe enforcement actions, penalties, or other regulatory details.
No publicly available information on the bill’s costs, budget effects, or administrative expenses is included in the bill text or provided metadata.
No publicly available information in the bill text describes proponents’ arguments or rationale. The bill was sponsored by Representative Gus Bilirakis with listed co-sponsors Laurel Lee, Vern Buchanan, and Lance Gooden.
No publicly available information in the bill text describes opponents’ arguments or concerns.